Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Norclobazam

Immunology & Autoimmune

DesmethylclobazamN-CLBN-desmethylclobazam

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the amount of norclobazam in your blood. Norclobazam is the main active metabolite of clobazam, a benzodiazepine medicine used to help control seizures. Measuring the metabolite helps your care team understand how your body processes clobazam and whether the exposure is appropriate for you.

Norclobazam levels are typically checked using a simple blood draw. Results are interpreted together with your dose, how long you have been on treatment, when the sample was taken in relation to your last dose, and how you are feeling.

Why it matters

Your clinician may order a norclobazam level to help fine tune therapy, especially if seizures persist, side effects are present, a dose change was made, or new medicines were added. It can help distinguish underdosing, nonadherence, or rapid metabolism from excessive exposure or drug interactions.

Levels are also useful in people with liver problems, older adults, or those with genetic differences that slow metabolism of norclobazam. Monitoring can reduce the risk of adverse effects such as excessive sleepiness, confusion, or unsteadiness while supporting effective seizure control.

Understanding your results

Your result is interpreted in context. The timing of the blood draw, your clobazam dose, other medicines, liver health, and your symptoms all matter. A value considered too low for you may reflect missed doses, fast metabolism, or sampling taken far from the usual trough time. A value considered high may increase the chance of side effects, especially if you feel overly sedated or unsteady.

Based on the result, your clinician may adjust the dose, change when you take your medicine, review other prescriptions and supplements for interactions, or in some cases consider genetic testing for drug metabolism. If you feel unwell or your seizures change, contact your care team promptly even if your last result seemed appropriate.

Reference ranges

210 umol/L
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Norclobazam

  • Sample timing

    Blood is usually drawn just before the next scheduled dose to reflect a trough level. Samples taken at other times can read higher or lower and may be harder to interpret accurately.

  • Other medications

    Medicines that affect liver enzymes can raise or lower norclobazam levels. Examples include certain antidepressants, antifungals, and seizure medicines. Always share a full medication list.

  • Liver function

    Norclobazam is processed in the liver. Liver disease or reduced function can increase levels and the risk of side effects, so dose adjustments or closer monitoring may be needed.

  • Genetic differences

    Differences in CYP2C19 activity can slow or speed the breakdown of norclobazam. People with reduced activity may have higher levels and need individualized dosing.

  • Age and frailty

    Older adults may clear the drug more slowly and be more sensitive to sedation and balance problems. Clinicians often target cautious dosing and monitor more closely.

  • Adherence and recent changes

    Missed doses, recent dose increases, or starting or stopping other drugs can shift levels. Tell the lab and your clinician about any changes so results are interpreted correctly.

2026

References

  1. McGill University Health Centre. (2006, August 25). Norclobazam (Task CD 793138). Laboratory reference ranges.
  2. Caudle, K. E., Sangkuhl, K., Whirl-Carrillo, M., & The CPIC Consortium. (2017). CPIC guideline for CYP2C19 and clobazam therapy. Clinical Pharmacology & Therapeutics.
  3. Patsalos, P. N., Spencer, E. P., & Berry, D. J. (2018). Therapeutic drug monitoring of antiepileptic drugs: A practical guide. Therapeutic Drug Monitoring.